A irway pressure release ventilation (APRV) is a relatively new mode of mechanical ventilatory support that has many similarities with other forms of pressure controlled mechanical ventilatory support. The inspiratory frequency, time, and pressure are set, as is expiratory pressure; however, tidal volume and minute ventilation vary as a function of respiratory mechanics. Additionally, like other modes of pressure controlled ventilatory support, the inspiratory flow in APRV is plotted over time, demonstrating a decelerating pattern. The unique characteristics of APRV relate to how it allows spontaneous patient inhalation and exhalation within wide ranges of force and flow during all mechanical phases of the respiratory cycle without changing the preset circuit pressure. This allows the mechanical inspiratory phase to be relatively prolonged to achieve high mean airway pressures (MAP) without causing harmful peak airway pressures (PAP) (Fig. 1 ). This is accomplished by the Drager Evita ventilator (Drager, Lubeck, Germany) with an electromagnetic expiratory valve pneumatically controlled with a microprocessor that allows regulation of the circuit pressure and flow available during both inspiration and expiration. A current is received by the coil of electromagnetic expiratory valve and moves a shaft that controls the pressure within the diaphragm. This free floating valve, regulated by the circuit pressure and flow, is sensitive to the patient's breathing cycle.
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In contrast to APRV, volume-controlled synchronized intermittent mandatory ventilation (SIMV), the most common mode of ventilatory support used in pediatric intensive care units (PICUs), delivers a preset tidal volume for each mechanical breath over a given time (Fig. 2) . Because spontaneous breathing is restricted during the mechanical inspiratory phase, patient respiratory effort often results in a high-pressure condition that causes discomfort and incomplete delivery of the set tidal volume. Prolonged inspiratory phase and reverse inspiratory/expiratory settings can usually be accomplished with heavy sedation and therapeutic neuromuscular blockade.
Previous studies and case reports in adult patients suggest that APRV provides a benefit by allowing oxygenation and ventilation to patients in respiratory failure (1) and acute lung injury (2). This Objectives: The purpose of this study was to determine the effectiveness of airway pressure release ventilation in children.
Design: Prospective, randomized, crossover clinical trial. Setting: This study was conducted in our 33-bed pediatric intensive care unit at The Children's Hospital of Philadelphia.
Patients: Patients requiring mechanical ventilatory support and weighing >8 kg were considered for enrollment. Patients were excluded if they required mechanical ventilatory support for >7 days or required >.50 FIO 2 for >7 days before enrollment. Patients with documented obstructive airway disease and congenital or acquired heart disease were excluded as well.
Interventions: Each patient received both volume-controlled synchronized intermittent mechanical ventilation (SIMV) and airway pressure release ventilation (APRV) via the Drager Evita ventilator (Drager, Lubeck, Germany). Measurements were obtained after the patient was stabilized on each ventilation mode. Stabilization was defined as oxygenation, ventilation, hemodynamic variables, and patient comfort within the acceptable range for each patient as determined by the bedside physician. After measurements were obtained on the initial mode of ventilation, the subjects crossed over to the alternative study mode. Stabilization was again achieved, and measurements were repeated.
After completion of the second study measurements, patients were placed on the ventilation modality preferred by the bedside clinician and were followed through weaning and extubation.
Measurements: Vital signs, airway pressures, minute ventilation, SPO 2 , and E T CO 2 were recorded at enrollment and at each study condition.
Main Results: APRV provided similar ventilation, oxygenation, mean airway pressure, hemodynamics, and patient comfort as SIMV. Inspiratory airway pressures were lower with APRV when compared with SIMV.
Conclusions: Using APRV in children with mild to moderate lung disease resulted in comparable levels of ventilation and oxygenation at significantly lower inspiratory peak and plateau pressures. Based on these findings, we plan to evaluate APRV in children with significant lung disease. can be accomplished while using lower peak airway pressure than is produced by SIMV and may significantly reduce the need for relaxants and sedatives (3). However, the benefits of APRV in the young have only been investigated in the experimental lab setting (4) . The purpose of the present study is to begin to examine the use of the APRV ventilator modality in children. We hypothesized that APRV would allow similar ventilation and oxygenation support with lower airway pressures without compromising patient comfort and hemodynamics.
MATERIALS AND METHODS
The Institutional Review Board approved this study at The Children's Hospital of Philadelphia. Written informed consent was obtained from each child's parent/guardian. Patients in the pediatric intensive care unit requiring mechanical ventilatory support and weighing Ͼ8 kg were eligible for the study. For this initial study, we wanted to include patients with mild to moderate lung disease; therefore, patients were excluded if they had received mechanical ventilatory support or FIO 2 of Ͼ0.5 for Ͼ7 days before enrollment. Similarly, children with restrictive airway disease and myocardial dysfunction (congenital or acquired) were excluded from the study. After enrollment, patients were randomly assigned to receive either APRV or SIMV as the initial form of ventilatory support via the Drager Evita ventilator. Ventilatory settings were then adjusted until stabilization was achieved. Stabilization was defined as oxygenation, ventilation, and patient comfort within acceptable range for each patient as determined by the bedside intensive care physician using vital signs (heart rate, respiratory rate, and blood pressure), physical exam, pulse oximetry (SPO 2 ), exhaled minute ventilation, and end tidal carbon dioxide (E T CO 2 ). When stable, vital signs, airway pressures, minute ventilation, SPO 2 and E T CO 2 measurements were recorded by using the devices routinely used to monitor patients in the PICU. The measurements were again recorded after patients were crossed over to the alternate mode (either SIMV or APRV) and ventilator adjustments to achieve stability were completed. Set peak end-expiratory pressure (PEEP) was left constant in both modes. After measurements were obtained in the two study modes, the clinicians directing the care of the patients were allowed to employ any technique that they felt best served the patients. Subjects were followed through their PICU course to weaning and extubation.
Airway pressures and minute ventilation were measured using the Bicore CP-100, (Bicore, Irvine, CA), which uses a Var Flex flow pneumotachometer placed at the proximal airway. Plateau pressures (P plat ) were assessed by utilizing the inspiratory hold function, and Auto-PEEP was assessed using the expiratory hold function of the Drager Evita technology.
Proximal airway E T CO 2 was measured continuously by using an infrared mainstream device, Nellcor 6000, (Nellcor, Pleasanton, CA). Pulse oximetry was also monitored continuously using the Nellcor 6000.
Comparison between modes for airway pressures (PAP, MAP, P plat ), tidal volume, respiratory rate and hemodynamic monitoring variables were made using a paired two tailed Student's t-test, and comparison between groups for changes in hemodynamic variables from study phase to baseline were made using one-way analysis of variance. All data are reported as mean Ϯ SD, unless otherwise specified. Statistical analysis was performed on a Macintosh personal computer with the statistical program, StatView 5.0 (SAS Institute, Cary, NC).
RESULTS
Fifteen patients were enrolled: six were girls (40%), and nine were boys (60%) ( Table 1 ). The mean age of enrolled patients was 10 yrs (range, 1-18 yrs). Nine patients started in SIMV and then crossed over to APRV (Group 1), and six patients started in APRV and then were crossed over to SIMV (Group 2) at the time of enrollment. Thirteen subjects (7 from Group 1 and 6 from Group 2) were subsequently managed and weaned to extubation in the APRV modality. The mean time of mechanical ventilatory support before enrollment was 10.2 hrs (range, 10 mins to 63 hrs). Stabilization was accomplished readily in both modes of ventilatory support as reflected in SPO 2 , FIO 2 , exhaled minute ventilation, and total respiratory rate (Table 2) . A small increase in E T CO 2 was noted in APRV (SIMV, 34 Ϯ 5 mm Hg; APRV, 36 Ϯ 6 mmHg; p Ͻ .05). However, when modalities were compared, large differences were noted in the inspiratory phase pressures. Both PAP (SIMV, 33 Ϯ 9 cm H 2 O; APRV, 19 Ϯ 7 cm H 2 O; p Ͻ .005) and P plat (SIMV, 23 Ϯ 8 cm H 2 O; APRV, 18 Ϯ 6 cm H 2 O; p Ͻ .005) were lower in the APRV mode (Table 2 and Figs. 3 and 4) . In contrast, no significant difference was noted in measured MAP (SIMV, 11 Ϯ 4 cm H 2 O; APRV, 10 Ϯ 4 cm H 2 O; p ϭ .12) ( Table 2) , and Auto-PEEP was not evident in any patient. Hemodynamic variables remained within 20% of baseline when subjects were in APRV and SIMV in both Group 1 and Group 2. In addition, no differences were noted in these variables when the two modes of ventilatory support were compared with one another (Table 3) .
DISCUSSION
The findings of this study indicate that the APRV modality can provide ad- equate ventilation, oxygenation, and patient comfort at lower airway pressures and without Auto-PEEP in children with mild or moderate lung disease. Current modes of positive pressure ventilation (volume control, pressure control, pressure support, minimum minute ventilation, and high-frequency ventilation) produce an inspiratory tidal volume by applying higher pressure to the airway than that present during the majority of the respiratory cycle. This technique may result in high inspiratory peak and plateau airway pressures comparative to the mean airway pressure. In turn, these inspiratory airway pressures may compromise cardiac output and cause pulmonary barotrauma (2) . Although lengthening the inspiratory time may reduce PAP and P plat as it improves MAP, this strategy, employed using most of the standardly available ventilators, may result in a reduction in minute ventilation and patient discomfort.
APRV, initially described in 1987 by Downs et al. (5) , was employed to augment alveolar ventilation during the application of continuous positive airway pressure, a mirror image of traditional use of positive expiratory pressure to improve oxygenation and lung volume recruitment during positive pressure ventilation. Subsequent comparisons of pulmonary mechanics and oxygenation in animals with acute lung injury (6) and adult trials of APRV suggested that this mode could be used to support oxygenation and ventilation by using lower peak airway pressures than produced by traditional IMV (1, 2, 7) while significantly reducing the need for relaxants and sedatives (3). Additionally, the investigators of APRV in an animal lab observed that the periodic decrease of airway pressure created by APRV did not cause a significant deterioration in oxygenation or lung mechanics (6) . The effect of APRV on circulatory function has been variable and remains in question (5, 7, 8) .
This study was designed to serve as a pilot study to help us understand the utility and feasibility of examining this ventilatory modality in a wider range of patients admitted to our PICU. Therefore, the current study population was limited to those with mild to moderate lung disease. As a consequence, few subjects had arterial access for neither blood-gas analysis nor other more invasive measures of pulmonary function. It is possible, therefore, that our findings may not be applicable to a more severely ill population and that the small differences noted in E T CO 2 actually represented a clinically important decrement in minute ventilation in the APRV mode. An alternative that we believe is more likely, however, is that APRV does provide similar support of minute ventilation at lower airway pressures and similar or superior maintenance of oxygenation and patient comfort. This conclusion is supported by our observation that the clinicians caring for the children judged 13 of 15 of them to be more comfortable on the APRV mode, resulting in APRV being used to continue treatment during weaning to extubation.
CONCLUSION
Using APRV in children with mild to moderate lung disease resulted in comparable levels of ventilation and oxygenation at significantly lower PAP and P plat . Based on these findings, we plan to evaluate APRV in children with significant lung disease. 
